Skip to main content
Premium Trial:

Request an Annual Quote

SNP Applications Seen Saving Healthcare Industry $1 Billion by 2010

NEW YORK, March 12 – The ability to identify and assess SNPs will help to increase treatment efficacy and reduce adverse drug reactions, helping to save the healthcare industry more than $1 billion over the next decade, a survey released Monday by Front Line Strategic Management Consulting said.

The Foster City, Calif.-based consultancy said that treatment efficacy could increase by 32 percent over current levels while adverse drug reactions could be reduced by up to 25 percent.

In addition, Front Line estimated that cost savings from pharmacogenomics could rise to $33 million per drug by the year 2010.

“Driving the savings will be SNP genotyping, which will directly reduce clinical trial sample size and subsequently the overall length of clinical development,” Front Line said. “The SNP genotyping market will experience exponential growth through 2005 due to an increased number of compounds for which SNP genotyping will be utilized in clinical trials. The adoption of this technology will eventually drive growth to an expected peak in 2005 as it reaches over a billion dollars in value.” 

After studying a drug already on the market, Front Line estimated that revenues would have been $3.5 billion, or 45 percent, higher over the life of the drug had pharmacogenomics been applied to the drug’s development. 

“This 45% increase in revenues was obtained by decreasing the overall length of the drug discovery and development process. This would have allowed for earlier market introduction and thereby, extend the time for revenue growth,” Front Line said.

The Scan

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.

Seagull Microbiome Altered by Microplastic Exposure

The overall diversity and the composition at gut microbiome sites appear to coincide with microplastic exposure and ingestion in two wild bird species, according to a new Nature Ecology and Evolution study.

Study Traces Bladder Cancer Risk Contributors in Organ Transplant Recipients

In eLife, genome and transcriptome sequencing reveal mutation signatures, recurrent somatic mutations, and risky virus sequences in bladder cancers occurring in transplant recipients.

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.